Reporting of clinical trial uncertainties with new cancer drugs in journal publications and clinical guidelines

Cherla, Avi, Wagner, Anita K., Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Woloshin, Steven, Davis, Courtney, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2025) Reporting of clinical trial uncertainties with new cancer drugs in journal publications and clinical guidelines. JAMA. ISSN 0098-7484

Text (JAMA-Sep-3) - Accepted Version Available under License Creative Commons Attribution. Download (207kB)

Abstract

This study assesses the reporting by journal publications and National Comprehensive Cancer Network (NCCN) guidelines of clinical uncertainties identified by the US Food and Drug Administration’s (FDA) Benefit-Risk Framework pertaining to cancer drugs approved in 2019-2022.

Item Type:	Article
Additional Information:	© 2025 American Medical Association
Divisions:	Health Policy
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	15 Sep 2025 14:21
Last Modified:	15 Sep 2025 15:03
URI:	http://eprints.lse.ac.uk/id/eprint/129524

Actions (login required)

View Item